C12N 2770/32243
Viral genome or elements thereof as genetic vector
Official title: viral genome or elements thereof as genetic vector
C12N2770/32243 (Viral genome or elements thereof as genetic vector) appears on 3 US grants and 6 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 6
- Assignees
- 7
- Inventors
- 22
- Latest grant
- 11 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 2 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Pharmaceutical composition containing stabilized nucleic acid adjuvant11 Nov 2025US 12,465,644 B2Sml Biopharm Co., Ltd.
- Compositions and methods for regulating mRNA transcription and translation24 May 2011US 7,947,493 B2Wisconsin Alumni Research Foundation
- Rapid, versatile and simple system for expressing genes in eukaryotic cells4 Aug 1992US 5,135,855 AThe United States of America as represented by the Department of Health and Human Services
- Encapsulated rna replicons and methods of use28 Dec 2023US 2023/0416308 A1Oncorus, Inc.
- Pharmaceutical composition containing stabilized nucleic acid adjuvant28 Jul 2022US 2022/0233700 A1Korea Institute of Science and Technology
- Reporter vector for evaluating characteristics of subject cell, assay kit, procedure and device20 Jul 2017US 2017/0204469 A1Toshiba Medical Systems Corporation
- Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins2 Jun 2005US 2005/0118566 A1
- Compositions and methods for regulating mRNA transcription and translation27 Jan 2005US 2005/0019808 A1Wisconsin Alumni Research Foundation
Most cited
By later US patents